Effects of Danshensu on the incidence of ischemia-reperfusion induced arrhythmia in hypertrophy rat heart

Chinese Journal of Natural Medicines

Volumn 6, Issue 6, 2008, Pages 461-465

  Le, Xiao Yong ^a   Chen, Chun Lin ^a   Ma, Liang ^a   Zhao, Na ^a   Tang, Yi Qun ^a   Liu, Xiao Quan ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Arrhythmia; Danshensu; Ischemia reperfusion; L thyroxine; Myocardial hypertrophy

Indexed keywords

3 (3,4 DIHYDROXYPHENYL)LACTIC ACID; CHINESE DRUG; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LEVOTHYROXINE; NITRIC OXIDE SYNTHASE; NITROGEN OXIDE; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; ISOLATED HEART; NONHUMAN; REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

EID: 57549117605     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.3724/SP.J.1009.2008.00461     Document Type: Article

References (10)

1. Yuan HJ. Pharmacological research new progress of Danshensu[J]. Chin J Hosp Pharm, 2006, 26(5): 604-606.
2. Wu L, Qiao H, Li Y, et al. Protective roles of purring and Danshensu on acute ischemic myocardial injury in rats[J]. Phytomedicine, 2007, 14 (10): 652-658.
3. Zhao GR, Zhang HM, Ye TX, et al. Characterization of the radical scavenging and antioxidant activities of Danshensu and salvianolic acid B[J]. Food Chem Toxicol, 2008, 46: 73-81
4. Feng Y, Da Dai DZ, Na T, et al. Endothelia receptor antagonist CPU 0213 suppresses ventricular fibrillation in L-thyroxin induced cardiomyopathy[J]. Pharmacol Rep, 2007, 59(3): 306-314.
5. Tang YQ, Zhang GQ, Dai DZ, et al. The establishment of the model of cardiac hypertrophy by Thyroxine[J]. Chin J Pathophysiol, 2001, 17(12): 1263-1264.
6. Wang T, Huang ZJ, Dai DZ, et al. Comparison of effects of dovetailed derivative V03(CPU228) and dofetilide on coronary occlusion and reperfusion arrhythmia, vascular contractions and proarrhythmic potential of torsade de pointes[J]. Chin Phar Bull, 2004, 20(5): 512-520.
7. Qi MY, Xia HJ, Dai DZ, et al. A novel endothelin receptor antagonist CPU0213 improves diabetic cardiac insufficiency attributed to up-regulation of the expression of FKBP12.6, SERCA2a and PLB in rats[J]. J Cardiovasc Pharmacol, 2006, 47(6): 729-735.
8. Wang HL, Li SB, Dai DZ. Change on L-type calcium current in single guinea pig hypertrophic ventricular myocytes induced by levothyroxine[J]. J China Pharm Univ, 2000, 31(2): 130-134.
9. Qian WM, Deng CY, Xue YM, et al. Effects of Danshensu on L-type calcium channels in isolated cardiomyocytes of guinea pig[J]. South China J Cardiovasc Dis, 2002, 8(4): 276-278.
10. Sun HY, Xue FS, Chen W, et al. Ischemia-reperfusion can reduce myocardial endogenous NO content in rats[J]. J Clin Anesthesiol, 2008, 24(1): 49-51.